Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension

Abstract Background To evaluate the safety and efficacy of bilateral balloon pulmonary angioplasty (BPA) as compared with unilateral BPA for patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Method We reviewed 210 consecutive BPA sessions for 92 CTEPH patients, includin...

Full description

Bibliographic Details
Main Authors: Cheng Hong, Jianmin Lu, Xiaofeng Wu, Wenliang Guo, Jielong Lin, Riken Chen, Haimin Liu, Haiming Chen, Yongxia Lei, Jian Wang, Yue Zhong, Chunying Zhuang, Xinlu Wang
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Respiratory Research
Subjects:
Online Access:https://doi.org/10.1186/s12931-022-02017-6
_version_ 1828789075963805696
author Cheng Hong
Jianmin Lu
Xiaofeng Wu
Wenliang Guo
Jielong Lin
Riken Chen
Haimin Liu
Haiming Chen
Yongxia Lei
Jian Wang
Yue Zhong
Chunying Zhuang
Xinlu Wang
author_facet Cheng Hong
Jianmin Lu
Xiaofeng Wu
Wenliang Guo
Jielong Lin
Riken Chen
Haimin Liu
Haiming Chen
Yongxia Lei
Jian Wang
Yue Zhong
Chunying Zhuang
Xinlu Wang
author_sort Cheng Hong
collection DOAJ
description Abstract Background To evaluate the safety and efficacy of bilateral balloon pulmonary angioplasty (BPA) as compared with unilateral BPA for patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Method We reviewed 210 consecutive BPA sessions for 92 CTEPH patients, including 124 unilateral BPA sessions and 86 bilateral BPA sessions. Radiation exposure, operation details, lesions characteristics and the occurrence of complications were compared between unilateral BPA and bilateral BPA. 131 BPA sessions with a hemodynamics follow-up were included for efficacy analysis, in which hemodynamics changes were compared. Logistic regression analysis was used to identify factors associated with the occurrence of complications. Result Bilateral BPA treated more lobes, arteries and lesions [3 (2, 4) vs. 2 (1, 3) lobes, p < 0.001; 8 (5.5, 10) vs. 6 (4, 8) vessels, p = 0.003; 9 (7, 12) vs. 8 (5, 10) lesions, p = 0.01] in one single session than unilateral BPA in a comparable operation duration and amount of contrast media given. Overall, the occurrence of complications was similar between bilateral BPA and unilateral BPA [9 (10.5%) vs. 12 (9.7%), p = 0.83]. Hemodynamics effects didn’t differ significantly between bilateral BPA and unilateral BPA in a single session [mPAP, − 4.5 ± 8.6 vs. − 3.6 ± 7.3 mmHg, p = 0.52; PVR, − 1.1 (− 3.5, 0.8) vs. − 1.8 (− 5.2, 0.3) Wood units, p = 0.21]. For the initial BPA session, bilateral BPA also treated more lobes, arteries and lesions than unilateral BPA [3 (2, 4) vs. 2 (1, 2) lobes, p < 0.001; 8.0 (5.8, 9.3) vs. 6.0 (4.0, 8.0) vessels, p = 0.04; 9 (6, 12) vs. 7 (4, 10) lesions, p = 0.02]. The occurrence of complications was also similar [5 (13.2%) vs. 5 (9.3%), p = 0.80], even in patients with poor baseline hemodynamics. Univariate regression analysis reveals the number of lobes treated/session, but not bilateral BPA, as predictive factors of complications. Conclusion Bilateral BPA may be safely and effectively performed in patients with CTEPH without increasing operation duration and radiation burden, even in patients with unfavorable baseline hemodynamics.
first_indexed 2024-12-12T01:04:33Z
format Article
id doaj.art-a5606bad178a4e03b8c0f2bd1b460264
institution Directory Open Access Journal
issn 1465-993X
language English
last_indexed 2024-12-12T01:04:33Z
publishDate 2022-05-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-a5606bad178a4e03b8c0f2bd1b4602642022-12-22T00:43:37ZengBMCRespiratory Research1465-993X2022-05-0123111210.1186/s12931-022-02017-6Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertensionCheng Hong0Jianmin Lu1Xiaofeng Wu2Wenliang Guo3Jielong Lin4Riken Chen5Haimin Liu6Haiming Chen7Yongxia Lei8Jian Wang9Yue Zhong10Chunying Zhuang11Xinlu Wang12State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityDepartment of Radiology, The First Affiliated Hospital of Guangzhou Medical UniversityState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityDepartment of Radiology, The First Affiliated Hospital of Guangzhou Medical UniversityState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityGuangzhou Medical UniversityState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical UniversityAbstract Background To evaluate the safety and efficacy of bilateral balloon pulmonary angioplasty (BPA) as compared with unilateral BPA for patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Method We reviewed 210 consecutive BPA sessions for 92 CTEPH patients, including 124 unilateral BPA sessions and 86 bilateral BPA sessions. Radiation exposure, operation details, lesions characteristics and the occurrence of complications were compared between unilateral BPA and bilateral BPA. 131 BPA sessions with a hemodynamics follow-up were included for efficacy analysis, in which hemodynamics changes were compared. Logistic regression analysis was used to identify factors associated with the occurrence of complications. Result Bilateral BPA treated more lobes, arteries and lesions [3 (2, 4) vs. 2 (1, 3) lobes, p < 0.001; 8 (5.5, 10) vs. 6 (4, 8) vessels, p = 0.003; 9 (7, 12) vs. 8 (5, 10) lesions, p = 0.01] in one single session than unilateral BPA in a comparable operation duration and amount of contrast media given. Overall, the occurrence of complications was similar between bilateral BPA and unilateral BPA [9 (10.5%) vs. 12 (9.7%), p = 0.83]. Hemodynamics effects didn’t differ significantly between bilateral BPA and unilateral BPA in a single session [mPAP, − 4.5 ± 8.6 vs. − 3.6 ± 7.3 mmHg, p = 0.52; PVR, − 1.1 (− 3.5, 0.8) vs. − 1.8 (− 5.2, 0.3) Wood units, p = 0.21]. For the initial BPA session, bilateral BPA also treated more lobes, arteries and lesions than unilateral BPA [3 (2, 4) vs. 2 (1, 2) lobes, p < 0.001; 8.0 (5.8, 9.3) vs. 6.0 (4.0, 8.0) vessels, p = 0.04; 9 (6, 12) vs. 7 (4, 10) lesions, p = 0.02]. The occurrence of complications was also similar [5 (13.2%) vs. 5 (9.3%), p = 0.80], even in patients with poor baseline hemodynamics. Univariate regression analysis reveals the number of lobes treated/session, but not bilateral BPA, as predictive factors of complications. Conclusion Bilateral BPA may be safely and effectively performed in patients with CTEPH without increasing operation duration and radiation burden, even in patients with unfavorable baseline hemodynamics.https://doi.org/10.1186/s12931-022-02017-6Chronic thromboembolic pulmonary hypertensionBalloon pulmonary angioplastyComplicationTreatment
spellingShingle Cheng Hong
Jianmin Lu
Xiaofeng Wu
Wenliang Guo
Jielong Lin
Riken Chen
Haimin Liu
Haiming Chen
Yongxia Lei
Jian Wang
Yue Zhong
Chunying Zhuang
Xinlu Wang
Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
Respiratory Research
Chronic thromboembolic pulmonary hypertension
Balloon pulmonary angioplasty
Complication
Treatment
title Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
title_full Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
title_fullStr Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
title_full_unstemmed Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
title_short Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
title_sort bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
topic Chronic thromboembolic pulmonary hypertension
Balloon pulmonary angioplasty
Complication
Treatment
url https://doi.org/10.1186/s12931-022-02017-6
work_keys_str_mv AT chenghong bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT jianminlu bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT xiaofengwu bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT wenliangguo bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT jielonglin bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT rikenchen bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT haiminliu bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT haimingchen bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT yongxialei bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT jianwang bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT yuezhong bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT chunyingzhuang bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension
AT xinluwang bilateralversusunilateralballoonpulmonaryangioplastyforinoperablechronicthromboembolicpulmonaryhypertension